Prevail Therapeutics Inc. Stock
Equities
PRVL
US74140Y1010
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Franz Hefti
CEO | Chief Executive Officer | 76 | 18-02-28 |
Jeffrey Sevigny
CTO | Chief Tech/Sci/R&D Officer | 55 | 18-02-28 |
Emily Minkow
PRN | Corporate Officer/Principal | 41 | 18-10-31 |
1st Jan change | Capi. | |
---|---|---|
-0.49% | 105B | |
+3.31% | 97.5B | |
+3.23% | 22.19B | |
-16.16% | 21.33B | |
-7.52% | 18.68B | |
-41.41% | 16.6B | |
-22.87% | 14.52B | |
+6.32% | 14.09B | |
+21.46% | 10.99B |